Aptamer Cell-Based Selection: Overview and Advances
AbstractAptamers are high affinity single-stranded DNA/RNA molecules, produced by a combinatorial procedure named SELEX (Systematic Evolution of Ligands by Exponential enrichment), that are emerging as promising diagnostic and therapeutic tools. Among selection strategies, procedures using living cells as complex targets (referred as “cell-SELEX”) have been developed as an effective mean to generate aptamers for heavily modified cell surface proteins, assuring the binding of the target in its native conformation. Here we give an up-to-date overview on cell-SELEX technology, discussing the most recent advances with a particular focus on cancer cell targeting. Examples of the different protocol applications and post-SELEX strategies will be briefly outlined. View Full-Text
Share & Cite This Article
Catuogno, S.; Esposito, C.L. Aptamer Cell-Based Selection: Overview and Advances. Biomedicines 2017, 5, 49.
Catuogno S, Esposito CL. Aptamer Cell-Based Selection: Overview and Advances. Biomedicines. 2017; 5(3):49.Chicago/Turabian Style
Catuogno, Silvia; Esposito, Carla Lucia. 2017. "Aptamer Cell-Based Selection: Overview and Advances." Biomedicines 5, no. 3: 49.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.